MOLECULAR TEMPLATES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.705 USD | +6.56% |
|
+15.99% | -54.29% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 708.1 | 469.2 | 220.7 | 18.48 | 20.05 | 11.23 | - |
| Enterprise Value (EV) 1 | 708.1 | 390.2 | 113.2 | 18.48 | 20.05 | 11.23 | 11.23 |
| P/E ratio | -7.52 x | -4.27 x | -2.61 x | -0.2 x | -2.07 x | -0.52 x | -0.43 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 31.8 x | 24.9 x | 5.7 x | 0.94 x | 0.35 x | 0.88 x | 8.21 x |
| EV / Revenue | 31.8 x | 24.9 x | 5.7 x | 0.94 x | 0.35 x | 0.88 x | 8.21 x |
| EV / EBITDA | - | -4,840,482 x | -3,005,223 x | -226,823 x | - | - | - |
| EV / FCF | - | -5,144,959 x | -6,419,323 x | - | - | - | - |
| FCF Yield | - | -0% | -0% | - | - | - | - |
| Price to Book | - | 7.91 x | 3.36 x | - | - | - | - |
| Nbr of stocks (in thousands) | 3,376 | 3,331 | 3,754 | 3,757 | 5,374 | 6,584 | - |
| Reference price 2 | 209.8 | 140.8 | 58.80 | 4.920 | 3.730 | 1.705 | 1.705 |
| Announcement Date | 3/12/20 | 3/18/21 | 3/28/22 | 3/30/23 | 3/29/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 22.27 | 18.84 | 38.7 | 19.75 | 57.31 | 12.7 | 1.367 |
| EBITDA | - | -96.92 | -73.44 | -81.49 | - | - | - |
| EBIT 1 | -48.33 | -100.8 | -80.07 | -88.87 | -10.47 | -23.67 | -36.4 |
| Operating Margin | -217% | -535.11% | -206.93% | -449.89% | -18.26% | -186.36% | -2,662.91% |
| Earnings before Tax (EBT) 1 | -69.42 | -104.9 | -83.01 | -92.66 | -8.135 | -22.42 | -34.74 |
| Net income 1 | -69.42 | -104.9 | -83.01 | -92.72 | -8.124 | -22.42 | -34.74 |
| Net margin | -311.72% | -556.73% | -214.51% | -469.36% | -14.18% | -176.5% | -2,541.26% |
| EPS 2 | -27.90 | -33.00 | -22.50 | -24.75 | -1.800 | -3.250 | -3.930 |
| Free Cash Flow | - | -91.19 | -34.38 | - | - | - | - |
| FCF margin | - | -483.89% | -88.85% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/18/21 | 3/28/22 | 3/30/23 | 3/29/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2.379 | 17.96 | 8.486 | 4.417 | 4.24 | 2.611 | 36.63 | 6.865 | 6.796 | 7.016 | 5.897 | 6.13 | 0.33 | 0.345 |
| EBITDA | -27.84 | -7.499 | - | -21.64 | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -29.53 | -9.301 | -20.63 | -23.84 | -23.67 | -21.06 | 11.78 | -11.74 | -5.137 | -5.371 | -4.476 | -3.545 | -7.942 | -7.709 |
| Operating Margin | -1,241.24% | -51.78% | -243.12% | -539.71% | -558.18% | -806.55% | 32.17% | -171.06% | -75.59% | -76.55% | -75.9% | -57.83% | -2,406.67% | -2,234.49% |
| Earnings before Tax (EBT) 1 | -30.39 | -10.24 | -21.61 | -24.74 | -24.61 | -22.02 | 10.84 | -10.87 | -4.153 | -3.959 | -4.253 | -3.165 | -7.552 | -7.45 |
| Net income 1 | -30.39 | -10.24 | -21.61 | -24.74 | -24.64 | -22.05 | 10.84 | -10.87 | -4.153 | -3.948 | -4.253 | -3.165 | -7.552 | -7.45 |
| Net margin | -1,277.3% | -57.02% | -254.67% | -560.22% | -581.08% | -844.47% | 29.61% | -158.31% | -61.11% | -56.27% | -72.12% | -51.63% | -2,288.48% | -2,159.42% |
| EPS 2 | -8.100 | -2.700 | -5.700 | -6.600 | -6.600 | -5.850 | 2.850 | -0.1900 | -0.8200 | -0.7300 | -0.7800 | -0.4700 | -1.110 | -0.8900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 3/28/22 | 5/13/22 | 8/11/22 | 11/10/22 | 3/30/23 | 5/15/23 | 8/10/23 | 11/13/23 | 3/29/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | 79 | 108 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | -91.2 | -34.4 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -129% | -133% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | 17.80 | 17.50 | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | 7.39 | 4 | - | - | - | - |
| Capex / Sales | - | 39.23% | 10.33% | - | - | - | - |
| Announcement Date | 3/12/20 | 3/18/21 | 3/28/22 | 3/30/23 | 3/29/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.705
USD
Average target price
18
USD
Spread / Average Target
+955.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -54.29% | 11.23M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- MTEM Stock
- Financials Molecular Templates, Inc.
